Shelter Pharma Ltd
Ticker: SHELTER
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
41.99
Market Cap
58.79
Debt/Equity
0.0243
ROE %
18.436
PB
1.3763
Promoter %
52.319
Pledge %
0.000
1Y Rev Growth %
26.612
5Y Rev Growth %
10.993
NP Margin %
14.289
NP Margin 5Y Avg %
10.233
Trading Reference
1M Return %
-4.072
6M Return %
5.902
1Y Return %
-8.717
% Away 52W High
65.992
% Away 52W Low
17.619
Daily Volume
57000
Investment Verdict
Buy
Score 83/100 · Position size: 40%
Long-term fundamentals are strong. Suitable for investors with a 1–3+ year horizon.
Trading Verdict
Avoid
Score 21/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Shelter Pharma Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If the stock breaks above the resistance level, there is a potential for significant upside. However, if it falls below the support, downside risks may increase.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
D
Dipna Pharmachem Ltd
Dipna Pharmachem Ltd shows decent potential but faces several challenges that could impact future performance.
View details
M
Madhucon Projects Ltd
Madhucon Projects Ltd shows potential in a growing sector but faces significant risks and inconsistencies in financial performance.
View details
S
Sacheta Metals Ltd
Sacheta Metals Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns. Caution is advised for potential investors.
View details
D
DMR Engineering Ltd
DMR Engineering Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns.
View details
A
Artefact Projects Ltd
Artefact Projects Ltd faces several challenges, including inconsistent growth and governance concerns, making it a risky investment at this time.
View details
S
Spinaroo Commercial Ltd
Spinaroo Commercial Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
I
Italian Edibles Ltd
Italian Edibles Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
View details
Z
Zodiac-JRD-MKJ Ltd
Zodiac-JRD-MKJ Ltd shows potential but faces challenges in growth consistency and market sentiment.
View details
N
N G Industries Ltd
N G Industries Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Y
Yamini Investments Company Ltd
Yamini Investments Company Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Shree Krishna Paper Mills & Industries Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
G
Garment Mantra Lifestyle Ltd
Garment Mantra Lifestyle Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Rasandik Engineering Industries India Ltd
Rasandik Engineering Industries presents a mixed outlook with several risks, particularly in growth consistency and market sentiment.
View details
G
Ganga Forging Ltd
Ganga Forging Ltd presents several risks with inconsistent growth and profitability metrics, alongside weak market sentiment.
View details
P
Pritish Nandy Communications Ltd
Pritish Nandy Communications Ltd presents several risks with inconsistent growth and profitability metrics, suggesting caution for investors.
View details
S
Super Spinning Mills Ltd
The stock shows several weaknesses in growth and profitability metrics, with risks outweighing potential rewards.
View details
Business Overview
Shelter Pharma Ltd is a pioneering pharmaceutical company dedicated to improving healthcare outcomes in India. Focused on innovative solutions, it caters to diverse medical needs, ensuring accessibility and affordability for patients across the country. With a commitment to research and development, Shelter Pharma is at the forefront of delivering high-quality medicines that enhance the quality of life. Its strategic partnerships and robust distribution network further solidify its position in the market, making it a trusted choice for healthcare professionals and patients alike.
- Pioneering pharmaceutical solutions
- Focus on accessibility and affordability
- Commitment to research and development
- High-quality medicines for better health
- Strong market presence and partnerships
Investment Thesis
Shelter Pharma Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. These factors position the company for sustained growth and profitability.
- Strong promoter group with a proven track record in the pharmaceutical sector.
- Robust growth potential in digital services, catering to evolving healthcare needs.
- Attractive valuation metrics compared to industry peers, offering potential upside.
- Commitment to innovation and R&D, enhancing competitive advantage.
- Favorable market conditions supporting expansion in the pharmaceutical industry.
Opportunity vs Risk
Opportunities
- Strong pipeline of new drugs
- Growing demand for healthcare solutions
- Potential for international expansion
- Strategic partnerships with major firms
Risks ⚠️
- Regulatory hurdles in drug approval
- High competition in the market
- Dependence on key products
- Market volatility affecting stock prices
Peer Perspective
Shelter Pharma Ltd trades at a 15% discount to peers like Sun Pharma and Cipla, primarily due to margin volatility; a sustained improvement in margins could trigger a rerating towards industry averages.
Future Outlook
Shelter Pharma Ltd has a promising pipeline that could drive growth, provided the company maintains strong execution and effective cost control. Continued focus on innovation will be key to unlocking its full potential.
AI FAQs for Retail Users
- Q: What does Shelter Pharma Ltd do?A: Shelter Pharma Ltd focuses on developing and manufacturing pharmaceutical products for various health conditions.
- Q: Is Shelter Pharma Ltd a profitable company?A: Profitability can vary; it's best to review recent financial reports for current performance.
- Q: What are the risks of investing in Shelter Pharma Ltd?A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical industry.
- Q: How can I buy shares of Shelter Pharma Ltd?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: Where can I find more information about Shelter Pharma Ltd?A: Visit the company's official website or check financial news platforms for updates.
📊 Stock Investment Checklist (100 Points)
Shelter Pharma Ltd • Updated: 2025-09-17 16:41:11
-
10BusinessHighPharmaceutical sector shows potential for growth, but competition is high.
-
10GrowthHighRevenue growth has been inconsistent, with recent fluctuations.
-
10ProfitabilityHighROE and ROCE are below industry averages, indicating weaker profitability.
-
8ValuationHighP/E ratio is higher than peers, suggesting overvaluation.
-
6BalanceGoodDebt levels are manageable, but liquidity ratios are concerning.
-
7GovernanceHighPromoter holding is decent, but there are some concerns about disclosures.
-
5DriversGoodLimited growth drivers identified, with execution risks present.
-
5TechnicalsGoodMarket sentiment is neutral, with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Shelter Pharma Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100